scholarly article | Q13442814 |
P2093 | author name string | A. B. Rabson | |
I. L. Miller | |||
B. J. Carter | |||
N. Chejanovsky | |||
B. A. Antoni | |||
J. P. Trempe | |||
P2860 | cites work | Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses | Q24627466 |
Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation | Q24646629 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone | Q33847737 | ||
The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity | Q34186060 | ||
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 | ||
Characterization of adeno-associated virus rep proteins in human cells by antibodies raised against rep expressed in Escherichia coli | Q36289406 | ||
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells | Q36425596 | ||
Mutation of a consensus purine nucleotide binding site in the adeno-associated virus rep gene generates a dominant negative phenotype for DNA replication | Q36804036 | ||
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. | Q36829325 | ||
Factors that bind to adeno-associated virus terminal repeats. | Q36829404 | ||
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein | Q36831270 | ||
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes | Q36838187 | ||
Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide | Q36869164 | ||
Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay | Q36873184 | ||
Positive and negative autoregulation of the adeno-associated virus type 2 genome | Q36883901 | ||
Construction of a genetic switch for inducible trans-activation of gene expression in eucaryotic cells | Q36887447 | ||
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants | Q36893013 | ||
Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product | Q36918659 | ||
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function | Q36918727 | ||
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 | ||
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells | Q37573696 | ||
Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant | Q37694247 | ||
Strategies for antiviral therapy in AIDS. | Q38172146 | ||
Regulatory pathways governing HIV-1 replication | Q38360638 | ||
Regulation of HIV and HTLV gene expression | Q39289382 | ||
Mysteries of HIV: challenges for therapy and prevention | Q39643153 | ||
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification | Q40109360 | ||
Defective-interfering particles of the human parvovirus adeno-associated virus | Q40227691 | ||
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 | ||
Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line | Q42811726 | ||
Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression | Q44389543 | ||
The AIDS virus | Q44559514 | ||
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. | Q44693409 | ||
Cloning of infectious adeno-associated virus genomes in bacterial plasmids | Q45796085 | ||
Inhibition of adenovirus oncogenicity in hamsters by adeno-associated virus DNA | Q45801062 | ||
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus | Q45801642 | ||
Inhibition of Adenovirus 12 Oncogenicity by Adeno-Associated Virus | Q45810680 | ||
Influence of adeno-associated satellite virus on adenovirus-induced tumours in hamsters | Q45819832 | ||
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector | Q45840914 | ||
Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells | Q45841628 | ||
The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus | Q45845384 | ||
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. | Q53896192 | ||
Expression and rescue of a nonselected marker from an integrated AAV vector. | Q54378201 | ||
Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function | Q58611466 | ||
Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor | Q64379115 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
microbiology | Q7193 | ||
viral gene expression regulation | Q70682269 | ||
viral replication | Q114773374 | ||
P304 | page(s) | 396-404 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells | |
P478 | volume | 65 |
Q41936136 | A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line. |
Q33952832 | A genetic screen identifies a cellular regulator of adeno-associated virus. |
Q35839786 | A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities |
Q39522533 | Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6 |
Q33799345 | Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16 |
Q34717163 | Adeno-associated virus rep protein-mediated inhibition of transcription of the adenovirus major late promoter in vitro |
Q35666040 | Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection. |
Q40039173 | Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. |
Q42428565 | Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat |
Q34064238 | An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. |
Q24646235 | Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels |
Q35877884 | Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products |
Q33653198 | Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro |
Q35879908 | Binding sites for adeno-associated virus Rep proteins within the human genome. |
Q36548752 | Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. |
Q39596582 | Charge-to-alanine mutagenesis of the adeno-associated virus type 2 Rep78/68 proteins yields temperature-sensitive and magnesium-dependent variants |
Q59359941 | Efficiency and Specificity of Targeted Integration Mediated by the Adeno-Associated Virus Serotype 2 Rep 78 Protein |
Q40964386 | Enhancement of UV-induced cytotoxicity by the adeno-associated virus replication proteins |
Q30877436 | Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo |
Q33819589 | Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins |
Q34341823 | Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. |
Q34015943 | How adeno-associated virus Rep78 protein arrests cells completely in S phase |
Q35844971 | Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters |
Q41101590 | Human immunodeficiency virus-1 proviral gene disruption by targeted gene therapy: a hypothetical technique for the elimination of provirus from the infected cells |
Q36641826 | Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins |
Q24293657 | Identification of a cytoplasmic interaction partner of the large regulatory proteins Rep78/Rep68 of adeno-associated virus type 2 (AAV-2) |
Q37748110 | Identification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter |
Q37033220 | Identification of cellular proteins that interact with the adeno-associated virus rep protein |
Q36624752 | Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. |
Q36690856 | In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of rep |
Q45879060 | Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virus |
Q35859014 | Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA. |
Q39871566 | Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters |
Q34057580 | Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein |
Q38356260 | PKA/PrKX activity is a modulator of AAV/adenovirus interaction |
Q40851727 | Prospects for virus-based gene therapy for cystic fibrosis |
Q34419803 | Proteins attached to viral genomes are multifunctional |
Q40933734 | Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy |
Q39878393 | Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line |
Q39873805 | Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers |
Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
Q39880225 | Role for highly regulated rep gene expression in adeno-associated virus vector production |
Q41381265 | Sequence elements of the adeno-associated virus rep gene required for suppression of herpes-simplex-virus-induced DNA amplification |
Q39580779 | Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. |
Q40510442 | Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. |
Q89783875 | The Carter Lab at NIH: A Model of Inclusive Excellence in Biomedical Research |
Q35865107 | The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene. |
Q34280639 | The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template |
Q22008522 | The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. |
Q35887002 | The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins |
Q40597354 | The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression |
Q38293578 | The trans‐inhibitory Rep78 protein of adeno‐associated virus binds to TAR region DNA of the human immunodeficiency virus type 1 long terminal repeat |
Q35228018 | Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells |
Q37945189 | Viral hybrid vectors for somatic integration - are they the better solution? |
Search more.